SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-24-001606
Filing Date
2024-10-16
Accepted
2024-10-16 08:34:46
Documents
15
Period of Report
2024-10-11
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e6034_8-k.htm   iXBRL 8-K 44215
2 EXHIBIT 17.1 e6034_ex17-1.htm EX-17.1 5839
3 EXHIBIT 17.2 e6034_ex17-2.htm EX-17.2 7821
  Complete submission text file 0001731122-24-001606.txt   243791

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE renb-20241011.xsd EX-101.SCH 3024
5 XBRL LABEL FILE renb-20241011_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE renb-20241011_pre.xml EX-101.PRE 24171
17 EXTRACTED XBRL INSTANCE DOCUMENT e6034_8-k_htm.xml XML 3682
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO INC. (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 241373364
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)